Our clinically aligned MSC platform is designed to support future therapeutic development through rigorous manufacturing and safety-focused quality standards.
Clinical Advantages
Our clinical-grade MSCs are manufactured under GMP-aligned conditions to support translational and clinical research applications. Each batch undergoes rigorous quality and safety testing, including sterility, mycoplasma, endotoxin, and viability assessments to ensure reliable performance. Cells are sourced from carefully screened and ethically obtained tissues with full traceability throughout the manufacturing process. With scalable production capabilities and consistent supply volumes, our MSC platform is designed to support early-phase clinical studies and advanced regenerative medicine programs. Selected for their strong immunomodulatory and regenerative properties, our MSCs provide significant potential for future therapeutic development.